Repair of Bone Erosion in Rheumatoid Arthritis by Denosumab: A High-Resolution Peripheral Quantitative Computed Tomography Study.

Item

http://www.wikidata.org/entity/Q47973046

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Repair of Bone Erosion in Rheu ...... ive Computed Tomography Study.

@en

Repair of Bone Erosion in Rheu ...... ive Computed Tomography Study.

@nl

type

Item

label

Repair of Bone Erosion in Rheu ...... ive Computed Tomography Study.

@en

Repair of Bone Erosion in Rheu ...... ive Computed Tomography Study.

@nl

prefLabel

Repair of Bone Erosion in Rheu ...... ive Computed Tomography Study.

@en

Repair of Bone Erosion in Rheu ...... ive Computed Tomography Study.

@nl

P1476

Repair of Bone Erosion in Rheu ...... tive Computed Tomography Study

@en

P2093

Defeng Wang

http://www.w3.org/2001/XMLSchema#string

Edmund K Li

http://www.w3.org/2001/XMLSchema#string

Fan Xiao

http://www.w3.org/2001/XMLSchema#string

Jiang Yue

http://www.w3.org/2001/XMLSchema#string

Jiayun Shen

http://www.w3.org/2001/XMLSchema#string

Martin Li

http://www.w3.org/2001/XMLSchema#string

Priscilla Wong

http://www.w3.org/2001/XMLSchema#string

Tena K Li

http://www.w3.org/2001/XMLSchema#string

Vivian W Hung

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Denosumab in postmenopausal women with low bone mineral density

Catabolic and anabolic periarticular bone changes in patients with rheumatoid arthritis: a computed tomography study on the role of age, disease duration and bone markers.

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont

Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis.

Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate.

P304

1156-1163

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACR.23133

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27768831

http://www.w3.org/2001/XMLSchema#string